Opioid Free Anesthesia in Breast Cancer Surgery
1 other identifier
interventional
80
1 country
1
Brief Summary
A comparison of incidences of postoperative nausea and vomiting (PONV) , postoperative pain severity and recovery parameters in breast cancer patients receiving opioid or opioid-free general anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2020
CompletedFirst Posted
Study publicly available on registry
May 15, 2020
CompletedStudy Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2022
CompletedApril 5, 2022
March 1, 2022
9 months
May 8, 2020
March 24, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
quality of recovery
15-item 15-item 15-item quality of recovery questionnaire
24 hours after surgery
Secondary Outcomes (3)
health related quality of life
up to 3 months after surgery
postoperative pain
up to 3 months after surgery
cancer recurrence and metastasis
up to 12 months after surgery
Study Arms (2)
nerve block+opioid-free general anesthesia
EXPERIMENTALParavertebral block with an ultrasound-guided technique; opioid-free general anesthesia
sham bock+opioid general anesthesia
SHAM COMPARATORSham block by local infiltration at the same site of paravertebral block; opioid based general aneshesia
Interventions
Paravertebral block will be performed at T2,T4 level on the surgical side using out-of-plane approach under ultrasound-guided, with 0.4% ropivacaine 20ml at each injection site.
propofol, lidocine and muscle relaxant will be used for induction, after laryngeal mask airway insertion, general anesthesia will be maintained.
Local infiltration at the same site of paravertebral block will be performed, with 1% lidocaine 3ml on each injection site.
propofol, sufentanil and muscle relaxant will be used for induction, after laryngeal mask airway insertion, general anesthesia will be maintained .
Eligibility Criteria
You may qualify if:
- first diagnosis of histologically confirmed primary breast cancer without known extension beyond the breast and axillary nodes;
- ASA physical statue I-II;
You may not qualify if:
- chronic pain and opioid administration history;
- allergy to local anesthetics or NSAIDs;
- coagulation disorders;
- local infection at regional block site;
- unable to comply to study protocol schedule for logistic or other reasons;
- refusal to participate to the study;
- breast reconstruction with implants or latissimus dorsi flap
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University People's Hospital
Beijing, Beijing Municipality, 100044, China
Related Publications (2)
Tripathy S, Rath S, Agrawal S, Rao PB, Panda A, Mishra TS, Nayak S. Opioid-free anesthesia for breast cancer surgery: An observational study. J Anaesthesiol Clin Pharmacol. 2018 Jan-Mar;34(1):35-40. doi: 10.4103/joacp.JOACP_143_17.
PMID: 29643620RESULTZhang Q, Wu Y, An H, Feng Y. Postoperative recovery after breast cancer surgery: A randomised controlled trial of opioid-based versus opioid-free anaesthesia with thoracic paravertebral block. Eur J Anaesthesiol. 2023 Aug 1;40(8):552-559. doi: 10.1097/EJA.0000000000001856. Epub 2023 May 23.
PMID: 37218631DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yi Feng, MD,PhD
Peking University People's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of the Anesthesiology Department
Study Record Dates
First Submitted
May 8, 2020
First Posted
May 15, 2020
Study Start
July 1, 2020
Primary Completion
March 15, 2021
Study Completion
March 15, 2022
Last Updated
April 5, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share